Benjamin F. Edwards & Company’s Ultragenyx Pharmaceutical RARE Stock Holding History

Benjamin F. Edwards & Company’s Portfolio RARE Stock Details RARE Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$4K	Buy
2024 Q1	$2K	Buy
2022 Q2	–	Sell
2022 Q1	$3K	Sell
2021 Q4	$62K	Hold
2021 Q3	$66K	Buy